Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyMSTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Any useful experiences with 4-Aminopyridine for walking?

A MyMSTeam Member asked a question 💭
Burlington, VT

First diagnosed with ms in my late 20s. In last five years I've had serious progression mostly with problems walking and now at 60 I have very limited mobility. I tried ampyra briefly but it gave me insomnia and headaches so my neurologist prescribed a compounded lower dose single release alternative. Would love to know if anyone else has tried this route. Weighing costs and benefits.

August 26
 · 
Reactions
MyMSTeam

It's great that your neurologist is working with you to find a more tolerable approach. Compounded lower-dose 4-aminopyridine (4-AP) is a route some people with MS explore when the standard extended-release version (Ampyra) causes side effects like the insomnia and headaches you experienced.

The standard version works by Show Full Answer

It's great that your neurologist is working with you to find a more tolerable approach. Compounded lower-dose 4-aminopyridine (4-AP) is a route some people with MS explore when the standard extended-release version (Ampyra) causes side effects like the insomnia and headaches you experienced.

The standard version works by improving nerve signal conduction in myelin-damaged fibers, which can help with walking ability — though it doesn't slow MS progression itself. Some things worth discussing with your neurologist when weighing costs and benefits:

- Side effects — the compounded lower dose may reduce issues like headaches and insomnia, but dizziness can still occur
- Seizure risk — Ampyra and its compounded alternatives are not recommended for people with a history of seizures or significant kidney issues
- Cost — compounded versions aren't FDA-approved, so insurance coverage can be inconsistent or limited
- Effectiveness — a lower dose may mean a reduced benefit for walking, so tracking any changes carefully is worthwhile Other MyMSTeam members have shared experiences navigating similar trade-offs with walking medications. Pairing any medication approach with physical therapy and appropriate assistive devices has also helped many people maintain as much mobility as possible.

Keeping an open, ongoing conversation with your neurologist about what you're noticing — good or bad — will be key to finding the right balance for you.

August 26

Related Questions

View All

Broken Toe Nail

A MyMSTeam Member asked a question 💭
Spfld, MA
February 13, 2014

Has baclofen pill made anyones stiffness worse??

A MyMSTeam Member asked a question 💭
Wytheville, VA
December 23, 2013

What kind of MS is this? RRMS or SPMS?

A MyMSTeam Member asked a question 💭
Los Angeles, CA
November 16, 2013 (edited)

What Walking With MS Gait Looks Like
Could Walking on the Treadmill Have Cognitive Benefits for People With MS?
4 Tips for Choosing a DMT To Treat MS (VIDEO)
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In